tiprankstipranks
Trending News
More News >
Suss Microtec (DE:SMHN)
XETRA:SMHN

Suss Microtec (SMHN) AI Stock Analysis

Compare
73 Followers

Top Page

DE:SMHN

Suss Microtec

(XETRA:SMHN)

Select Model
Select Model
Select Model
Outperform 73 (OpenAI - 4o)
Rating:73Outperform
Price Target:
€41.00
▼(-7.03% Downside)
Suss Microtec's overall score is driven by strong technical indicators and a solid financial position, despite cash flow challenges. The valuation is reasonable, but earnings call insights highlight significant risks in order intake and margin pressure.
Positive Factors
Revenue Growth
Consistent revenue growth indicates strong demand for Suss Microtec's products, supporting long-term business expansion and market presence.
Strong Balance Sheet
Low leverage enhances financial stability, providing Suss Microtec with flexibility to invest in growth opportunities and withstand economic fluctuations.
New Facility in Taiwan
The new facility enhances production capacity and positions Suss Microtec to capitalize on growth in the semiconductor industry, particularly in Asia.
Negative Factors
Decreased Order Intake
A significant drop in order intake suggests weakening demand, which could impact future revenue and profitability if not addressed.
Pressure on Margins
Margin pressure from product mix challenges may reduce profitability, necessitating strategic adjustments to sustain earnings.
Negative Free Cash Flow
Negative free cash flow indicates potential liquidity issues, limiting Suss Microtec's ability to fund operations and growth without external financing.

Suss Microtec (SMHN) vs. iShares MSCI Germany ETF (EWG)

Suss Microtec Business Overview & Revenue Model

Company DescriptionSÜSS MicroTec SE, together with its subsidiaries, develops, manufactures, and markets machines for the production of microelectronics, microelectromechanical systems, and related applications. It operates through five divisions: Photomask Equipment, Lithography, Bonder, Microoptics, and Others. The company develops, manufactures, and sells mask aligners, coaters and developers, UV projection scanners, and laser processing tool. It develops, produces, and sells bonder systems, including microelectromechanical systems, compound semiconductors, and 3D integration markets. In addition, the company develops, manufactures, and sells specialized tools for the cleaning and processing of photomasks for the semiconductor industry. Further, it is involved in the production and sale of micro lenses and specialized optics for various industrial applications. It operates in Europe, the Middle East, Africa, North America, and the Asia Pacific. The company distributes its products through production facilities, as well as through distribution companies and trade representatives. SÜSS MicroTec SE was founded in 1949 and is headquartered in Garching, Germany.
How the Company Makes MoneySuss Microtec generates revenue primarily through the sale of its specialized equipment and systems used in semiconductor manufacturing. The company offers a range of products that cater to various stages of the microelectronics production process, including development and high-volume manufacturing. Key revenue streams include direct sales of equipment, maintenance services, and consumables. Additionally, Suss Microtec benefits from long-term partnerships with major semiconductor manufacturers and research institutions, which provide a stable customer base and opportunities for collaborative development projects. The company's focus on innovation and technology advancement also positions it favorably for growth in emerging markets, such as the automotive electronics sector, further contributing to its earnings.

Suss Microtec Earnings Call Summary

Earnings Call Date:Nov 06, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Mar 30, 2026
Earnings Call Sentiment Neutral
The earnings call presented a mixed outlook with positive developments in sales performance and cost management, but significant challenges remain in terms of order intake, margin pressure, and cash flow. The company is optimistic about future orders and new product launches, but current figures indicate areas of concern.
Q3-2025 Updates
Positive Updates
Sales and Revenue On Track
After 3 quarters, the company reached EUR 384 million, which is 78% of the midpoint of their sales forecast, indicating they are on track to meet their expectations for the year.
Strong Performance in Imaging and Coating Systems
Imaging and Coating Systems showed year-on-year sales growth of over 50% each, indicating robust demand in these areas.
New Facility in Taiwan
The opening of a new site in Zhubei, Taiwan, with large clean rooms, indicates readiness for future growth and received strong support from key industry figures.
Cost Management Success
Short-term cost-cutting measures resulted in savings of over EUR 5 million compared to Q2, demonstrating effective financial management.
Negative Updates
Decreased Order Intake
The order intake was EUR 70 million in Q3, and the order book is down 35.9% compared to the previous year, indicating a significant drop in demand.
Pressure on Margins
Gross profit margin faced significant pressure, with a decrease to 31.7% in Q3 due to an unfavorable product mix and postponed high-margin projects.
Challenges in Photomask Solutions
The Photomask Solutions segment experienced a very low order intake, with orders from China down EUR 32 million compared to the previous year.
Negative Free Cash Flow
Free cash flow from continuing operations was minus EUR 0.7 million in the third quarter, with a total of minus EUR 28.2 million after 3 quarters.
Company Guidance
In the recent conference call, SUSS MicroTec SE provided guidance for its financial performance, highlighting several key metrics. The company reported a low order intake of EUR 70 million in Q3 but anticipates orders exceeding EUR 100 million in Q4. Year-to-date sales reached EUR 384 million, or 78% of the midpoint of their sales forecast, with a Q3 sales figure of EUR 118 million. For Q4, sales are expected to range between EUR 85 million and EUR 125 million to meet their annual forecast. The current gross profit margin stands at 31.7%, impacted by an unfavorable product mix, while the EBIT margin has been adjusted following cost management efforts. The order book at the end of September was EUR 276.1 million, down 35.9% from the previous year. Free cash flow for the first three quarters was negative EUR 28.2 million, with expectations to end the year slightly positive. SUSS anticipates a CapEx level of EUR 25 million for the year, driven mainly by their new facility in Taiwan. The company remains optimistic about future growth and improving its cost structure, with details to be discussed at their Capital Markets Day on November 17.

Suss Microtec Financial Statement Overview

Summary
Suss Microtec shows strong revenue growth and robust profitability margins, supported by a solid balance sheet with low leverage. However, significant challenges in cash flow management, particularly in free cash flow generation, present a potential risk.
Income Statement
Suss Microtec shows strong revenue growth with a TTM increase of 9.24%. The gross profit margin is healthy at 39.62%, and the EBIT margin is robust at 17.66%. However, the net profit margin has decreased from 24.73% in 2024 to 11.89% in TTM, indicating pressure on net profitability.
Balance Sheet
The company maintains a low debt-to-equity ratio of 0.05, indicating prudent financial leverage. Return on equity is strong at 21.93% in TTM, reflecting efficient use of equity. The equity ratio is stable, suggesting a solid financial position.
Cash Flow
Cash flow performance is mixed, with a significant decline in free cash flow growth at -160.07% in TTM. The operating cash flow to net income ratio is low, indicating challenges in converting income into cash. However, the free cash flow to net income ratio remains relatively high, suggesting some resilience.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue535.29M446.15M304.26M259.97M263.44M252.91M
Gross Profit199.44M178.35M103.89M110.07M94.19M84.49M
EBITDA93.50M86.17M35.61M37.65M29.61M28.21M
Net Income53.00M110.34M4.70M24.52M16.02M12.36M
Balance Sheet
Total Assets522.94M538.23M369.73M353.16M279.17M231.41M
Cash, Cash Equivalents and Short-Term Investments94.94M136.37M49.02M61.51M53.60M41.03M
Total Debt50.53M13.29M15.18M20.00M18.32M20.49M
Total Liabilities218.69M258.49M193.12M175.43M122.29M94.90M
Stockholders Equity304.25M279.75M176.62M177.73M156.88M136.50M
Cash Flow
Free Cash Flow-25.46M26.64M434.00K16.04M14.71M47.21M
Operating Cash Flow-6.32M33.49M3.79M23.94M24.33M55.16M
Investing Cash Flow-24.77M71.85M-8.18M-17.84M-9.62M-11.16M
Financing Cash Flow-10.39M-7.90M-8.02M-6.77M-3.83M-13.28M

Suss Microtec Technical Analysis

Technical Analysis Sentiment
Positive
Last Price44.10
Price Trends
50DMA
35.49
Positive
100DMA
32.94
Positive
200DMA
34.85
Positive
Market Momentum
MACD
2.26
Negative
RSI
67.48
Neutral
STOCH
89.74
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:SMHN, the sentiment is Positive. The current price of 44.1 is above the 20-day moving average (MA) of 39.93, above the 50-day MA of 35.49, and above the 200-day MA of 34.85, indicating a bullish trend. The MACD of 2.26 indicates Negative momentum. The RSI at 67.48 is Neutral, neither overbought nor oversold. The STOCH value of 89.74 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DE:SMHN.

Suss Microtec Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
€224.32M6.4934.03%94.73%83.64%
76
Outperform
€2.34B24.3810.99%0.88%-3.93%-20.93%
74
Outperform
€1.84B14.7122.08%1.08%-5.55%21.30%
73
Outperform
€895.37M15.8919.94%0.78%34.77%52.20%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
52
Neutral
€1.62B-57.35-1.40%0.43%-5.17%-128.32%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DE:SMHN
Suss Microtec
44.10
2.43
5.82%
DE:AIXA
AIXTRON
19.62
4.83
32.61%
DE:ELG
ELMOS Semiconductor
106.40
29.36
38.11%
DE:M5Z
Manz AG
0.07
-0.26
-79.39%
DE:WAF
Siltronic
51.80
6.63
14.68%
DE:CTNK
centrotherm international AG
10.60
7.24
215.48%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 18, 2025